Janumet XR is a type-2 diabetes medication that contains sitagliptin, a controversial new drug that has been linked to reports of pancreatitis and pancreatic cancer. Merck is now facing a growing number of lawsuits from plaintiffs who allege that they were not adequately warned about the risk.
What You Can Do & How a Janumet XR Lawsuit Can Help
The Schmidt Firm, PLLC is currently accepting Janumet XR induced injury cases in all 50 states. If you or somebody you know was injured by Janumet XR, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.
UPDATE: FDA Warning Links Janumet XR and Severe Joint Pain
Janumet XR Lawsuits Centralized in Federal Litigation
If you decide to file a Janumet XR lawsuit, you may be eligible to join a federal Multi-District Litigation (MDL) that already contains over 150 lawsuits. Like a class action, the MDL centralizes many lawsuits into one court, which improves efficiency and reduces costs. However, unlike a class action, individual lawsuits remain independent, and plaintiffs keep their own lawyer to fight for justice and compensation.
Janumet XR lawsuits could be transferred here:
- U.S. District Court for the Southern District of California, under the Honorable Anthony J. Battaglia: In RE: Incretin Mimetics Products Liability Litigation (MDL No. 2452)
What is Janumet XR?
Merck & Co.’s new diabetes medicine Janumet XR contains a combination of metformin (extended-release) and sitagliptin. In addition to diet and exercise, Janumet XR helps lower blood-sugar levels in adults with type-2 diabetes. It was approved by the FDA in February 2012.
What is the problem?
Many experts are concerned that Janumet XR may increase a person’s risk of pancreatitis or pancreatic cancer. Researchers are still investigating, and it could be many years before adequate studies are conducted. Our lawyers are concerned that Merck & Co. is not doing enough to warn people about the increasing amount of evidence linking Janumet XR and cancer.
Contact us if you took Janumet XR and developed:
- Pancreatitis (pancreatic inflammation)
- Hemorrhagic or necrotizing pancreatitis
- Pancreatic cancer
- Micro-adenomas or neuroendocrine tumors
- And more
FDA Warnings for Janumet XR
- August 25, 2009 — Drug Safety Communication — The FDA has received 88 reports of acute, hemorrhagic, and necrotizing pancreatitis in people on sitagliptin.
- March 14, 2013 — Drug Safety Communication — FDA warns about a study published in Diabetes linking sitagliptin to pre-cancerous pancreatic growths.
Do I have a Janumet XR Lawsuit?
The Schmidt Firm, PLLC is currently accepting diabetes drug induced injury cases in all 50 states. If you or somebody you know was injured by Janumet XR, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.